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Abstract—Gene expression profiles have become an 
important and promising way for cancer prognosis and 
treatment. In addition to their application in cancer class 
prediction and discovery, gene expression data can be used for 
the prediction of patient survival. Here, we use particle swarm 
optimization (PSO) to address one of the major challenges in 
gene expression data analysis, the curse of dimensionality, in 
order to discriminate high risk patients from low risk patients. 
A discrete binary version of PSO is used for gene selection and 
dimensionality reduction, and a probabilistic neural network 
(PNN) is implemented as the classifier. The experimental 
results on the diffuse large B-cell lymphoma data set 
demonstrate the effectiveness of PSO/PNN system in survival 
prediction. 
Keywords—Gene expression data, Probabilistic neural 
networks, Particle swarm optimization, Cancer survival 
prediction. 
I. INTRODUCTION
 Gene expression profiles have become an important and 
promising way for cancer prognosis and treatment. 
Particularly, their applications for cancer class prediction 
and discovery have already attracted numerous efforts from 
a wide variety of research communities [1-4]. On the other 
hand, prediction of patient survival, based on gene 
expression profiles, is also useful in choosing appropriate 
therapy [3-11]. This link provides an effective means to 
overcome the insufficiency of traditional methods in cancer 
research, which are largely dependent on the morphological 
appearance of tumors or the parameters derived from 
clinical observations. Several studies have been done for 
patient survival analysis based on either hierarchical 
clustering or statistical regression [3-11]. For example, 
Garber et al. used hierarchical clustering to divide 
adenocarcinoma tumors into three groups, and significant 
differences in patient survival rates is observed in these 
groups [4]. Bair and Tibshirani calculated the Cox score to 
find genes whose expression levels are correlated with 
patient survival and only performed clustering on the 
selected important high-scored genes [8]. However, 
machine learning and neural network technologies, which 
have achieved many appealing results in microarray data 
analysis, are also worth exploring for this problem. 
 Here, we propose a hybrid system, consisting of two 
important technologies in machine learning and neural 
networks, i.e., particle swarm optimization (PSO) and 
probabilistic neural networks (PNN), to perform survival 
analysis on a diffuse large B-cell lymphoma (DLBCL) data 
set [5]. PSO is an evolutionary computation technique for 
global optimization, which is based on the simulation of 
complex social behavior [12]. We use PSO to address one of 
the major challenges of microarray data analysis: the 
overwhelming number of measures of gene expression 
levels compared with the small number of samples. This is 
known as the curse of dimensionality [15]. Not all of these 
genes (features) are relevant to a specific tumor type, and 
the inclusion of the unrelated genes in the data analysis not 
only increases the computational complexity, but makes the 
results hard to interpret and prevents determining the 
appropriate therapy. Therefore, gene selection is critically 
important. By using PSO in gene selection, we consider the 
ability of PSO to balance global and local exploration, its 
effectiveness in achieving high-quality solutions, and the 
memory mechanism for keeping track of previous best 
solutions and therefore, avoiding the possible loss of 
previously learned knowledge. PNN was introduced as an 
implementation of nonparametric Pazen window estimation 
with feed-forward neural network architecture [14]. PNN 
has the advantage of fast training, only one user dependent 
parameters, and the capability to approximate arbitrarily 
complex decision boundaries, and has already shown 
appealing performance in cancer identification [2]. 
 The paper is organized as follows. Section II describes 
the PSO/PNN system for survival analysis. The 
experimental results on DLBCL data set are presented and 
discussed in section III. Section IV concludes the paper. 
II. METHODS 
 PSO is motivated by the behavior of bird flocking or 
fish schooling and originally intended to explore optimal or 
near-optimal solutions in sophisticated continuous spaces 
[12]. A randomized velocity is associated with each 
potential solution, called a particle in the swarm. These 
particles change their positions in the search space until a 
stop condition is satisfied. The basic idea of PSO is to 
accelerate each particle towards two best locations at each 
time step, where one is the previous best solution for the 
particle, based on the calculated fitness value, and the other 
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is the best overall value in the whole swarm. The basic 
concept of PSO is depicted in Fig. 1.  
 Since our goal is to select a subset of important genes 
(features) from a large gene pool and therefore reduce the 
dimensionality, we use a discrete binary version of PSO 
[13]. The major change of the binary PSO comes from the 
re-explanation of the meaning of the particle velocity. Given 
a set of particles ( )1 2, ,..., N=X x x x , where N is the number 
of particles in the swarm, the velocity for the ith particle 
( )1 2, ,...,i i i iDx x x=x  , where D is the number of dimensions 
in a particle, is represented as ( )1 2 , ,...,i i i iDv v v=v . The 
possible values for each bit idx  (1 ,  1i N d D≤ ≤ ≤ ≤ ) is 
either one or zero, indicating whether the corresponding 
genes are selected or not. Its velocity  idv  is explained as the 
probability that  idx  takes the value of one, and is squashed 
into the interval [0,1]  through a logistic function 
 ( ) 1/(1 exp( ))id idS v v= + − .  The basic procedure of binary 
PSO for gene selection is as follows: 
i). Initialize a population of N particles with random 
positions and velocities. The dimensionality D of the 
problem space is dependent on the number of genes 
in the data set. 
ii). Evaluate the classification performance of the 
classifier and calculate the optimization fitness 
function for each particle. Here, the design of fitness 
function aims to minimize the classification error and 
also favor the subset with fewer genes, which is 
defined as 
( ) 1/i LOOCVf Acc n= +x ,                        (1) 
where
number of correctly 
classified patients 100%
total number of patientsLOOCV
Acc = ×  is 
the leave one out cross validation (LOOCV) [15]  
classification accuracy and n is the number of genes 
selected. 
iii). Compare the fitness value of the ith particle with its 
previous best position pi. If the current value is better 
than pi, reset both pi and location to the current value 
and location. 
iv). Compare the fitness value of each particle with the 
global best position pg. If current value is better than 
pg, reset pg to the current particle’s array index and 
value. 
v). Update the velocity and position of the particle with 
the following equations. 
                       1 1
2 2
( )      
       ( )
id id id id
gd id




= × + × × −
+ × × −
         (2)  
31    if  ( )






= ⎨⎩                       (3)           
   where idx  and idv  are the position and velocity of the 
dth dimensionality of the ith particle, respectively, w
is the inertia weight, 1c  and 2c  are the acceleration 
constants, ?1, ?2, and ?3 are uniform random 
functions in the range of [0, 1], ? is a parameter that 
limits the total number of genes selected to some 
certain range, and S() is the sigmoid function. 
Compared with the original binary PSO in [13], we 
add the parameter ? in order to control the number of 
selected genes more flexibly.     
vi). Return to step ii until the stop condition is satisfied, 
usually a maximum number of iterations or high-
quality solutions.  
 The velocity update of a PSO particle in (2) comprises 
three parts. The first is the momentum part, which prevents 
abrupt velocity change. The second is the “cognitive” part, 
which represents learning achieved from its own search 
experience.  The third is the “social” part which represents 
the cooperation among particles – learning from the group 
best’s search experience. The inertia weight w controls the 
balance of global and local search ability. A large w
facilitates the global search while a small w enhances local 
search. The velocity for each particle is restricted to a limit 
Vmax. During the evolutionary procedure, the velocity is re-
assigned to Vmax if it exceeds Vmax. For binary PSO, this 
limits the probability that a bit in a particle takes on the 
value of one. Usually, the smaller Vmax is, the higher the 
mutation rate [13]. 
A typical PNN architecture is illustrated in Fig. 2, 
which consists of three layers: input layer, pattern layer and 
category layer [14-15]. The input layer works as a 
distribution mechanism and receives input components from 
the data set. Therefore, the number of nodes in this layer is 
equal to the dimension of the input vector. All of these 
nodes are fully connected with the nodes in the pattern 
layer, which is considered as the key of PNN. PNN requires 
m pattern nodes if the total number of training patterns is m,
so that each pattern node can correspond to a training 
pattern. In contrast to the link between input and pattern 
xi(t) w vi(t)




Fig. 1. .  Concept of a swarm particle’s position.  xi(t) and vi(t) denote the 
particle’s position and the associated velocity vector in the searching
space at generation t, respectively.  Vector c1 ?1 (pi- xi(t)) and c2 ?2 (pg-
xi(t)) describe the particle’s “cognitive” and “social” activities,
respectively.  The new velocity vi(t+1) is determined by the momentum
part, “cognitive” part, and “social” part. The particle’s position at
generation t+1 is updated with xi(t) and vi(t+1). 
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layers, the nodes of pattern and category layers are sparsely 
connected. Each pattern node is only connected to the 
category node that correctly indicates its associated class. 
PNN calculates the Bayesian posterior probability for each 
category. During the training phase, the weights connecting 
the input and pattern layer are simply set as the copy of 
input vectors, i.e. ,  for  1,...,i i i n= =w x . This process is 
one of the fastest known training strategies. During the test 
phase, each pattern node performs a dot product operation 
with a new pattern vector x and a weight vector iw ,
expressed as iiP wx •= . The final output pattern layer is 
obtained via a nonlinear transformation. Usually a Gaussian 
activation function ( )2exp ( 1) /iP σ−  is used.  Here, σ is the 
smoothing parameter of the Gaussian kernel and is also the 
only user-dependent parameter. Note that if both the training 
patterns and the new patterns are normalized to unit length, 
the output of pattern layer can be represented as 






















  ,            (4)  
which is identical to the Parzen window function. In this 
sense, each pattern node provides the corresponding 
category node with the class conditional probability given 
the training pattern. These values are then summed up in the 
category layer for each category as the estimated probability 
for the new pattern. The label of the pattern can be predicted 
by just choosing the maximum probability. 
III. RESULTS
 We performed the survival analysis on the DLBCL data 
set of Resenwald et al., which consists of measurements of 
7,399 genes from 240 patients [5]. The data set is divided 
into a training set with 160 patients and a test set with 80 
patients. The survival time for the patients ranges from 0 to 
21.8 years. Any patient who lived longer than the median 
survival time (2.8 years) is placed into the low-risk group, 
otherwise, into the high-risk group. For those censored 
patients who left the follow-up before the median, we 
estimated the probability of their survival according to the 
Kaplan-Meier survival curve and then assigned its label.  
 During the training phase, we used leave one out cross 
validation as the error estimation for gene selection. Each 
time, a different single sample was left out as the test point 
and the other samples were used for training. Then we 
evaluated the prediction performance of the classifier on the 
independent test set.  
 We set the parameters for PSO as follows: w=0.7, 
1 2 2c c= = , and Vmax=2. We adjusted the value of ? in order 
to control the total number of selected genes in the subsets. 
Each time, the evolution is processed for 200 generations 
with 30 particles included in the swarm. The smoothing 
parameter of the Gaussian kernel is set to 2. Unlike other 
algorithms, we only have four parameters that are user-
dependent. Their values can be easily determined and the 
performance is not sensitive to their change [2]. Fig.3 shows 
the Kaplan-Meier curves for the estimation of patient 








Fig. 2. PNN architecture. Each pattern node represents a pattern in the 
training set. The Bayesian posterior probability for each category is 
obtained as the output of the corresponding category node.
(a) 
(b)
Fig. 3. Kaplan-Meier curves show significant differences in survival of 
the high-risk and low-risk group, based on the performance of PSO/PNN 
on the training set (a) and the independent test set (b).
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set ? as 0.49, which leads to the selection about 92-185 
genes. We chose the subset consisting of 113 genes that can 
achieve 80% classification accuracy on the test set and drew 
the curves. We also increased or decreased the value of ? to 
check the effect of gene subsets on the classification rate. 
We find in both ways, the performance is deteriorated. For 
example, the best result for the subsets including 5-30 genes 
is 73%. When all genes are used, the classification accuracy 
is only 52%. These results reflect the importance of gene 
selection in the prediction of clinical phenotypes, as its 
application in tumor classification [1-2]. We applied the log-
rank test to test the difference between the low-risk and 
high-risk group, each of which is associated with a survival 
curve, as depicted in Fig. 3. The p-values for both the 
training set and the test set are less than 0.0001, which 
indicates the significant difference between the two risk 
groups, divided by the PSO/PNN method. There are 11 
patients with less than 2.8 years survival time that are 
misclassified into the low-risk group in the test set. For the 5 
misclassifications in the high-risk group, four of them are 
censored and the other is a patient died at 3.1 years. 
Furthermore, we calculated the frequency of each gene 
appearing in the selected 210 subsets. We find that the 
selection frequencies of 5 genes are more than 13% and 
those of 34 genes are more than 10%. This shows that PSO 
tends to choose a subset of genes associated with the 
phenotype in spite of the different initial conditions. 
However, the challenge to find the relation of genes with the 
survival still remains open due to the existing uncertain 
factors [16].  
IV. CONCLUSION 
 We have proposed a PSO/PNN system for the analysis 
of patient survival through their gene expression profiling, 
which can be a significant factor for pharmaceutical 
selection and treatment. PSO is an effective computational 
technique for global optimization, in this case, for the 
selection of a subset of genes relevant to the phenotype. 
This process, which is also can be regarded as 
dimensionality reduction, is critically important in this type 
of analyses since cancer data sets usually consist of 
overwhelming number of measurements of gene expression 
levels compared with a very small set of samples. The 
experiment results on the DLBCT data set demonstrate that 
the methods can be very useful in connecting the clinical 
observance with gene expression profiling. Further research 
includes the simulation study on more survival data sets, the 
further investigation of the selected genes, and the 
application of a hybrid of PSO and evolutionary algorithm 
(EA) for gene selection. This design considers the 
complementary properties of PSO and EA and is more 
powerful for optimization.  
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